Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Acute Respiratory Distress Syndrome / Severe ARDS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT04340557
What this trial is testing

Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection

Who this might be right for
SARS-CoV Infection
Sharp HealthCare 31
Not applicableStudy completedNCT05693051
What this trial is testing

Use of Prone Position Ventilation in Danish Patients With COVID-19 Induced Severe ARDS Treated With VV-ECMO

Who this might be right for
ARDS, HumanExtracorporeal Membrane OxygenationCOVID-19 Acute Respiratory Distress Syndrome+2 more
Rigshospitalet, Denmark 68
Not applicableStudy completedNCT05012267
What this trial is testing

Duration of Prone Position in the Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19).

Who this might be right for
Ards
Ignacio Saez de la Fuente 61
Large-scale testing (Phase 3)Study completedNCT04640194
What this trial is testing

Test Whether Different Doses of Alteplase Help People With Severe Breathing Problems Because of COVID-19

Who this might be right for
Acute Respiratory Distress Syndrome
Boehringer Ingelheim 104
Large-scale testing (Phase 3)Ended earlyNCT01014364
What this trial is testing

Low Doses Corticosteroids as Adjuvant Therapy for the Treatment of Severe H1N1 Flu

Who this might be right for
Pneumonia, ViralInfluenza in Humans
University of Versailles 40
Large-scale testing (Phase 3)Study completedNCT06729593
What this trial is testing

Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

Who this might be right for
Covid19
National Institute of Allergy and Infectious Diseases (NIAID) 87
Not applicableUnknownNCT04659460
What this trial is testing

RIC as an Adjunct Therapy for Severe COVID-19 Disease: a Prospective Randomized Pilot Study

Who this might be right for
COVIDCorona Virus InfectionAcute Lung Injury+2 more
Unity Health Toronto 30
Not applicableStudy completedNCT05933291
What this trial is testing

Single-cell Landscape of BALF in Patients With Severe ARDS and CARDS

Who this might be right for
ARDS: Acute Respiratory Distress SyndromeCovid19
Peking Union Medical College Hospital 8
Not applicableStudy completedNCT03021824
What this trial is testing

Severe ARDS: Generating Evidence

Who this might be right for
Acute Respiratory Distress SyndromeAcute Respiratory Failure With HypoxiaAcute Respiratory Failure
Montefiore Medical Center 2,400
Testing effectiveness (Phase 2)WithdrawnNCT07492888
What this trial is testing

Nogapendekin Alfa-Inbakicept and iNKT Cells for Critically Ill Adults With Severe Community-Acquired Pneumonia (With or Without Sepsis/ARDS)

Who this might be right for
Acute Respiratory Distress SyndromeSevere Community-Acquired PneumSepsis+1 more
ImmunityBio, Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT05938036
What this trial is testing

Study of Safety and Efficacy of ALT-100mAb in Participants With Moderate/Severe ARDS

Who this might be right for
Acute Respiratory Distress Syndrome (ARDS)
Aqualung Therapeutics Corp. 15
Not applicableStudy completedNCT05697666
What this trial is testing

Impact of the Depth of Neuromuscular Blockade on Respiratory Mechanics in Moderate to Severe ARDS Patients

Who this might be right for
Acute Respiratory Distress SyndromeVentilator-Induced Lung Injury
Centre Hospitalier de Saint-Brieuc 33
Testing effectiveness (Phase 2)UnknownNCT04416139
What this trial is testing

Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19

Who this might be right for
Covid 19
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 10
Not applicableStudy completedNCT04603755
What this trial is testing

Electrical Impedance Tomography: Collapse in Dependent Areas as a Predictor of Response to Prone Position Ventilation in COVID-19 Acute Respiratory Distress Syndrome

Who this might be right for
SARS-CoV InfectionAcute Respiratory Distress Syndrome
Direction Centrale du Service de Santé des Armées 50
Testing effectiveness (Phase 2)Study completedNCT03567577
What this trial is testing

Safety and Preliminary Efficacy of Sequential Multiple Ascending Doses of Solnatide to Treat Pulmonary Permeability Oedema in Patients With Moderate-to-severe ARDS

Who this might be right for
ARDS
Apeptico Forschung und Entwicklung GmbH 92
Very early researchStudy completedNCT04998253
What this trial is testing

Effects in Oxygenation and Hypoxic Pulmonary Vasoconstriction in ARDS Secondary to SARS-CoV2

Who this might be right for
Hypoxic Pulmonary VasoconstrictionHypoxemiaAcute Respiratory Distress Syndrome+1 more
Unidad Temporal COVID-19 en Centro Citibanamex 24
Not applicableLooking for participantsNCT03753412
What this trial is testing

Recovery From ICUAW Following Severe Respiratory and Cardiac Failure

Who this might be right for
Intensive Care Unit SyndromeIntensive Care NeuropathyIntensive Care (ICU) Myopathy+4 more
Barts & The London NHS Trust 100
Not applicableUnknownNCT01690819
What this trial is testing

Protective Ventilatory Strategy in Severe Acute Brain Injury

Who this might be right for
Injuries, Acute Brain
University of Turin, Italy 524
Not applicableStudy completedNCT05207202
What this trial is testing

Effect of EIT-guided PEEP Titration on the Prognosis of Patients with Moderate to Severe ARDS

Who this might be right for
Clinical Outcomes
Southeast University, China 190
Testing effectiveness (Phase 2)UnknownNCT04397497
What this trial is testing

Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19)

Who this might be right for
Covid-19Acute Respiratory FailureARDS, Human+2 more
Ospedale San Raffaele 50
Next Page